With the analysis among 9,967 patents, we discovered top 451 key players by total patent application. Merck & Co., Inc., Agensys, Inc., F. Hoffmann-La Roche Ltd. are dominant in this area. They take 6.36% of the total patent filing.
New Jersey, United States
Patent: 258
California, United States
Patent: 219
F. Hoffmann-La Roche Ltd.
Basel-Stadt, Switzerland
Patent: 144
New York, United States
Patent: 128
Washington, United States
Patent: 96
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 90
Boston Scientific Scimed, Inc.
Minnesota, United States
Patent: 73
With the analysis among 213 patents, we discovered top 42 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Biosplice Therapeutics, Inc., Medicametrix, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Biosplice Therapeutics, Inc.
California, United States
Patent: 21
Massachusetts, United States
Patent: 19
California, United States
Patent: 14
Niedersachsen, Germany
Patent: 11
Shenzhen Jieguan Dexin Technology Co., Ltd.
Guangdong Sheng, China
Patent: 10
Minnesota, United States
Patent: 8
Targimmune Therapeutics AG
Basel-Stadt, Switzerland
Patent: 7
With the analysis among related 2,880 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing The Johns Hopkins University, NYMOX CORPORATION, Janssen Biotech take 5.31% of patent filing during this period.
The Johns Hopkins University
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 34
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
TRUSTEES OF THE UNIV OF PENNSYLVANIA
Pennsylvania, United States
Patent: 31
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 31
Technische Universität München
Bayern, Germany
Patent: 29
Purdue Research Foundation
Indiana, United States
Patent: 23
With the analysis among related 2,880 patents in last 5 years, we discover 287 new entrants. Technische Universität München, Institut régional du Cancer de Montpellier, Codagenix, Inc. are the most active new entrants in this area.
Technische Universität München
Bayern, Germany
Patent: 29
Institut régional du Cancer de Montpellier
New York, United States
Patent: 18
Gyeonggi-do, South Korea
Patent: 15
Advanced Accelerator Applications (Italy) SRL
Heidelberg Pharma Research GmbH
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 14
Niedersachsen, Germany
Patent: 11
Eureka Therapeutics, Inc.
California, United States
Patent: 10
With the analysis among 3,142 patents, we discovered top 265 universities and scientific research institutions by total patent application. The Johns Hopkins University, University of British Columbia, Ruprecht-Karls-Universität Heidelberg are dominant in this area. They take 12.41% of the total patent filing.
The Johns Hopkins University
University of British Columbia
British Columbia, Canada
Patent: 84
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 63
Council of Scientific & Industrial Research
New York, United States
Patent: 29
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 29
Technische Universität München
Bayern, Germany
Patent: 29
Harbin University of Science & Technology
Heilongjiang Sheng, China
Patent: 25
Thomas Jefferson University
Pennsylvania, United States
Patent: 23
Baylor College of Medicine
Texas, United States
Patent: 23